Successful treatment with pembrolizumab for microsatellite instability-high thymic carcinoma: A case report
Introduction: Thymic carcinoma is a rare, aggressive malignancy, and in cases of metastasis, palliative chemotherapy is the typical treatment. Microsatellite instability (MSI)-high tumors are more likely to respond to immune checkpoint inhibitors, such as pembrolizumab, than to other types of chemot...
Saved in:
Main Authors: | Yuichi Sakamori, Kentaro Hamada, Hiroaki Kawachi, Mako Yamoto, Akari Fukao, Satoshi Terashita, Kizuku Watanabe, Tatsuyoshi Ikeue, Takakazu Sugita |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221300712500108X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case report: administration of immune checkpoint inhibitor for SMARCB1 (INI1)-negative rhabdoid carcinoma with microsatellite instability (MSI)-high in the right colon
by: Toshinori Kobayashi, et al.
Published: (2023-02-01) -
Successful anti-PD-1 therapy in metastatic endometrial cancer with microsatellite instability: a case report
by: T. T. Andabekov, et al.
Published: (2019-07-01) -
Parallel Phase II Clinical Trials of Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma
by: Chul Kim, MD, et al.
Published: (2025-09-01) -
Pigmented spindle cell variant of a thymic atypical carcinoid in an octogenarian
by: Yasushi Sakamaki, et al.
Published: (2021-01-01) -
A spontaneous reduction in tumor size of a thymic carcinoma: a case report
by: Shoei Kuroki, et al.
Published: (2022-08-01)